Biblioteca Humberto Rosselli Quijano
Información del autor
Autor A. Eden Evins |
Documentos disponibles escritos por este autor (3)
![](./images/expand_all.gif)
![](./images/collapse_all.gif)
![Selecciones disponibles](./images/orderby_az.gif)
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders / A. Eden Evins en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 6 (Diciembre)
[artículo]
Título : A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders Tipo de documento: texto impreso Autores: A. Eden Evins, Autor ; Melissa A. Culhane, Autor ; Jonathan E. Alpert, Autor Fecha de publicación: 2023 Artículo en la página: pp. 660-666 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Bupropión, Terapia de modalidad combinada, Trastorno depresivo, Nicotina, Agonistas nicotínicos, Abandonos de pacientes, Tabaquismo, Dejar de fumar - métodos, Tabaquismo - Prevención, Trastorno por consumo de tabaco. Resumen: Although there is a strong relationship between depression and smoking, most nicotine dependence treatment trials exclude depressed smokers. Our objective was to determine whether bupropion improves abstinence rates and abstinence-associated depressive symptoms when added to transdermal nicotine replacement therapy (NRT) and group cognitive behavioral therapy (CBT) in smokers with unipolar depressive disorder (UDD). Link: ./index.php?lvl=notice_display&id=30825
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 660-666[artículo] A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders [texto impreso] / A. Eden Evins, Autor ; Melissa A. Culhane, Autor ; Jonathan E. Alpert, Autor . - 2023 . - pp. 660-666.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 660-666
Palabras clave: Bupropión, Terapia de modalidad combinada, Trastorno depresivo, Nicotina, Agonistas nicotínicos, Abandonos de pacientes, Tabaquismo, Dejar de fumar - métodos, Tabaquismo - Prevención, Trastorno por consumo de tabaco. Resumen: Although there is a strong relationship between depression and smoking, most nicotine dependence treatment trials exclude depressed smokers. Our objective was to determine whether bupropion improves abstinence rates and abstinence-associated depressive symptoms when added to transdermal nicotine replacement therapy (NRT) and group cognitive behavioral therapy (CBT) in smokers with unipolar depressive disorder (UDD). Link: ./index.php?lvl=notice_display&id=30825 A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia / A. Eden Evins en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 3 (Junio)
[artículo]
Título : A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia Tipo de documento: texto impreso Autores: A. Eden Evins, Autor ; Corinne Cather, Autor ; Thilo Deckersbach, Autor Fecha de publicación: 2023 Artículo en la página: pp. 218-225 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Bupropión, Esquizofrenia, Tabaquismo, Fumar - metabolismo, Tabaquismo - psicología Resumen: The objective of this study was to examine the efficacy of bupropion for smoking cessation in patients with schizophrenia. Adults with schizophrenia who smoked more than 10 cigarettes per day and wished to try to quit smoking were recruited from community mental health centers, enrolled in a 12-week group cognitive behavioral therapy intervention, and randomly assigned to receive either bupropion sustained-release 300 mg/d or identical placebo. Link: ./index.php?lvl=notice_display&id=30905
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 218-225[artículo] A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia [texto impreso] / A. Eden Evins, Autor ; Corinne Cather, Autor ; Thilo Deckersbach, Autor . - 2023 . - pp. 218-225.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 218-225
Palabras clave: Bupropión, Esquizofrenia, Tabaquismo, Fumar - metabolismo, Tabaquismo - psicología Resumen: The objective of this study was to examine the efficacy of bupropion for smoking cessation in patients with schizophrenia. Adults with schizophrenia who smoked more than 10 cigarettes per day and wished to try to quit smoking were recruited from community mental health centers, enrolled in a 12-week group cognitive behavioral therapy intervention, and randomly assigned to receive either bupropion sustained-release 300 mg/d or identical placebo. Link: ./index.php?lvl=notice_display&id=30905 A double blind, placebo-controlled trial of the NMDA glycine site antagonist, gw468816, for prevention of relapse to smoking in females / A. Eden Evins en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 5 (Octubre)
[artículo]
Título : A double blind, placebo-controlled trial of the NMDA glycine site antagonist, gw468816, for prevention of relapse to smoking in females Tipo de documento: texto impreso Autores: A. Eden Evins, Autor ; Gladys Pachas, Autor ; David Mischoulon, Autor Fecha de publicación: 2022 Artículo en la página: pp. 597-602 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Nicotina, Dejar de fumar, NMDA, Glutamato, Prevención de recaídas, Glicina Resumen: Relapse to smoking is common after initial abstinence with pharmacotherapy and behavioral support and represents a major clinical challenge. Although mechanisms underlying relapse to smoking have not been elucidated, preclinical studies suggest that glutamate receptors may be involved. Link: ./index.php?lvl=notice_display&id=29355
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 597-602[artículo] A double blind, placebo-controlled trial of the NMDA glycine site antagonist, gw468816, for prevention of relapse to smoking in females [texto impreso] / A. Eden Evins, Autor ; Gladys Pachas, Autor ; David Mischoulon, Autor . - 2022 . - pp. 597-602.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 597-602
Palabras clave: Nicotina, Dejar de fumar, NMDA, Glutamato, Prevención de recaídas, Glicina Resumen: Relapse to smoking is common after initial abstinence with pharmacotherapy and behavioral support and represents a major clinical challenge. Although mechanisms underlying relapse to smoking have not been elucidated, preclinical studies suggest that glutamate receptors may be involved. Link: ./index.php?lvl=notice_display&id=29355